Using Preoperative Anxiety Score to Determine the Total Dose of Butorphanol for Sedation
NCT ID: NCT03810391
Last Updated: 2019-01-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
126 participants
INTERVENTIONAL
2017-12-01
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Using Preoperative Anxiety Score to Determine the Precise Dose of Butorphanol for Sedation
NCT03429179
The Impact of Anxiety or Depression on the Sedative Concentration of Propofol
NCT03741361
Preoperative Anxiety Level, Premedications and General Anaesthetic Proceedings
NCT03603873
Impact of Anxiety on the Decision-making Processes of Anesthesiologists
NCT05364801
Effect of Propofol on Postoperative Sleep Quality in Elderly Patients With Sleep Disorders
NCT05325762
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
preoperative anxiety and butorphanol
preoperative anxiety scores of patients in Group A were \>11 and received an intravenous loading dose of 15ug/kg butorphanol 5 min before starting the surgery, then followed by infusion of 7.5ug/kg/h butorphanol and stopped infusion until the Ramsay sedation score reached 4 points
Butorphanol
intravenous loading dose of 15ug/kg butorphanol,and followed by infusion of 7.5ug/kg/h butorphanol and stopped infusion until the Ramsay sedation score reached 4 points
preoperative anxiety and saline
preoperative anxiety scores of patients in Group B were \>11 and received an infusion of the same volume of physiological saline
physiological saline
intravenous infusion of the same volume of physiological saline
non-preoperative anxiety and butorphanol
preoperative anxiety scores of patients in Group C were ≤ 11 and received an intravenous loading dose of 15ug/kg butorphanol 5 min before starting the surgery, then followed by infusion of 7.5ug/kg/h butorphanol and stopped infusion until the Ramsay sedation score reached 4 points
Butorphanol
intravenous loading dose of 15ug/kg butorphanol,and followed by infusion of 7.5ug/kg/h butorphanol and stopped infusion until the Ramsay sedation score reached 4 points
non-preoperative anxiety and saline
preoperative anxiety scores of patients in Group D were ≤11 and received an infusion of the same volume of physiological saline
physiological saline
intravenous infusion of the same volume of physiological saline
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Butorphanol
intravenous loading dose of 15ug/kg butorphanol,and followed by infusion of 7.5ug/kg/h butorphanol and stopped infusion until the Ramsay sedation score reached 4 points
physiological saline
intravenous infusion of the same volume of physiological saline
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18-75 years
* Scheduled for elective low limb orthopaedic procedures under spinal anesthesia
Exclusion Criteria
* cardiovascular disease
* autonomic nervous system disease
* long term use of analgesic, sedative, and anti-anxiety drugs
* psychosis
* a patient with a language communication disorder not willing to cooperate with the experimenter
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shengjing Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yanchao Yang
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Junchao Zhu, professor
Role: STUDY_DIRECTOR
Shengjing Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
shengjing hospital of China medical university
Shenyang, Liaoning, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Effect of butorphanol
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.